Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Clonal origin and spread of metastatic prostate cancer
Jamie L. Van Etten,
Scott M. Dehm
Masonic Cancer Center
Laboratory Medicine and Pathology
Cellular Mechanisms of Cancer
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clonal origin and spread of metastatic prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
100%
Metastatic Disease
100%
Clonal Origin
100%
Clonal Spread
100%
Prostate Cancer
66%
Genetic Evolution
66%
Disease Progression
33%
Circulating Tumor Cells
33%
Castration-resistant Prostate Cancer
33%
Metastasis
33%
Androgen Deprivation Therapy
33%
Sequencing Studies
33%
Clonal Evolution
33%
Response to Therapy
33%
Circulating Tumor DNA (ctDNA)
33%
Disease Stage
33%
Prostate Cancer Risk
33%
Genome Composition
33%
Resistance to Therapy
33%
Large-scale Sequencing
33%
Disease Regression
33%
Prostate Cancer Genome
33%
Metastatic Site
33%
Surgical Castration
33%
Chemical Castration
33%
Spatial Landscape
33%
Cell Tumor
33%
Health-to-disease Transition
33%
Medicine and Dentistry
Prostate Cancer
100%
Metastatic Carcinoma
80%
Disease
20%
Circulating Tumor Cell
20%
Disease Exacerbation
20%
Spontaneous Remission
20%
Androgen Deprivation Therapy
20%
Castration Resistant Prostate Cancer
20%
Cancer Mortality
20%
Circulating Tumor DNA
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Metastasis
60%
Disease Exacerbation
20%
Remission
20%
Castration Resistant Prostate Cancer
20%
Circulating Tumor DNA
20%
Cancer Mortality
20%
Disease
20%
Neoplasm
20%
Androgen
20%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Circulating Tumor DNA
50%
Cancer Mortality
50%
Clonal Evolution
50%
Genomics
50%
Material Science
Tumor
100%
Phase Composition
50%
Agricultural and Biological Sciences
Androgen
100%